Korea Prime Pharm

Korea Prime Pharm is a South Korean pharmaceutical company established in 1995, specializing in the development, manufacture, and distribution of ethical (ETC) and over-the-counter (OTC) medicines. The company maintains a strong focus on cardiovascular, central nervous system, and gastrointestinal therapeutics, offering a diverse portfolio of generic drugs and incrementally modified drugs (IMDs). Korea Prime Pharm operates a KGMP-certified manufacturing facility in Hwasun and a dedicated R&D center in Gwangju that focuses on new drug delivery systems (NDDS) and fixed-dose combination therapies. The firm also provides CMO and CDMO services to domestic and international partners, leveraging its specialized manufacturing capabilities for tablets, capsules, and specialized formulations.